Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | NLGN1: potential biomarker of Alzheimer’s disease

Jonathan Brouillette, PhD, University of Montreal, Montreal, Quebec, Canada, discusses neuroligin-1 (NLGN1) as an early biomarker of Alzheimer’s disease (AD). This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).